Stockscreener 앱 받기
0.356
1.08%
-0.0039
시간 외 거래:
.36
0.004
+1.12%
전일 마감가:
$0.3599
열려 있는:
$0.3698
하루 거래량:
61,230
Relative Volume:
0.55
시가총액:
$3.99M
수익:
$19.98M
순이익/손실:
$-2.66M
주가수익비율:
-0.8711
EPS:
-0.4087
순현금흐름:
$-2.65M
1주 성능:
-8.69%
1개월 성능:
-23.61%
6개월 성능:
-52.34%
1년 성능:
-66.10%
1일 변동 폭
$0.335
$0.3698
1주일 범위
$0.33
$0.412
52주 변동 폭
$0.33
$2.56
cbdMD Inc Stock (YCBD) Company Profile
명칭
cbdMD Inc
전화
704-445-5800
주소
4521 Sharon Road, Charlotte, NC
Compare YCBD vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.356 | 3.99M | 19.98M | -2.66M | -2.65M | -0.4087 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
cbdMD Inc 주식(YCBD)의 최신 뉴스
What Does cbdMD, Inc.'s (YCBD) Latest Move Mean for Cannabis Stocks Investors? - Kalkine Media
Why Is cbdMD (NYSE American:YCBD) Buying Twinlab Brand Assets? - Kalkine Media
Cbdmd Stock Price Forecast. Should You Buy YCBD? - StockInvest.us
cbdMD to buy Twinlab as supplement M&A heats up - SupplySide Supplement Journal
YCBD Q2 2026 Earnings: Deep Loss Miss Raises Questions as Shares Fall 3.76%Revenue Growth Outlook - vinanet.vn
Twinlab Assets Acquired by cbdMD Amid Creditor Assignment - The Globe and Mail
cbdMD to Acquire Twinlab's Legacy Supplement Brands - Nutritional Outlook
cbdMD to Acquire Twinlab Brands, Expanding Consumer Wellness Portfolio - citybiz
CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. - marketscreener.com
cbdMD acquires legacy supplement brand Twinlab - NutraIngredients.com
cbdMD’s Acquisition of Supplement Legacy Brand Twinlab Creates Unique Synergy - WholeFoods Magazine
cbdMD agrees to acquire Twinlab brands - Chain Drug Review
Twinlab Sets Asset Sale to cbdMD for $3.98 Million; Consideration Goes to Akretive - TradingView
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com Nigeria
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com India
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com
cbdMD to acquire Twinlab brands, boosting reven... - Pluang
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com UK
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire
cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView
YCBD | cbdMD, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingAnalyst Drop Coverage - siam.in
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingEarnings Quality Analysis - vinanet.vn
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingForward EPS Estimate - dars.gov.et
cbdMD Inc (YCBD) Stock News Today - TradingKey
Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5 - Moomoo
YCBD Downgraded by Maxim Group -- Rating Changed to Hold - GuruFocus
Maxim Group Downgrades cbdMD to Hold From Buy - marketscreener.com
Conferencia de resultados del T3 fiscal de 2026 de CBDMD (YCBD): los ingresos aumentan un 20%, objetivo de reducción de costos - TradingKey
cbdMD Inc (YCBD) Stock News Today - TradingKey
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance
YCBD Q3 FY2026 earnings call - finance.biggo.com
cbdMD Q3 2026 Earnings Call: Complete Transcript - Benzinga
Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours - Investing.com
Transcript : CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
cbdMD Q3 FY2026 Earnings: Revenue Grows 20% as Gross Margin Narrows - TradingKey
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - PR Newswire
cbdMD, Inc. (NYSE: YCBD) grows sales to $16.2M amid going concern warning - Stock Titan
cbdMD (NYSE American:YCBD): What Does the Latest Update Mean for Brand Demand? - Kalkine Media
cbdMD reports 20% revenue growth in Q3 2026, dr... - Pluang
cbdMD schedules conference call on quarterly results - Bitget
cbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11) - scanx.trade
cbdMD schedules conference call on quarterly results - Bitget
cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan
cbdMD to discuss Q3 2026 financial results in c... - Pluang
cbdMD Inc (YCBD) Stock News Today - TradingKey
cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
cbdMD Inc. (YCBD) Holds Steady at $0.58 as Traders Eye Key $0.55–$0.61 RangePoint of Control - vinanet.vn
CBD Gummy Bears Stock SymbolView gF7h08LSE - Diario AS
Senate bill proposes delay of hemp product restrictions By Investing.com - Investing.com UK
cbdMD Inc (YCBD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
cbdMD Inc 주식 (YCBD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Clark R. Crosnoe, CRC Investme | Stockholder |
Dec 17 '25 |
Proposed Sale |
2.25 |
986,851 |
2,220,415 |
0 |
3.81%
3.58%
자본화:
|
볼륨(24시간):